SLP: כמות מזומנים למניה Simulations Plus, Inc.

The net cash position per share on the GURU.Markets terminal chart, where the current value is 2.47, confirms the status of Simulations Plus, Inc. (SLP) as a dominant player in biosimulation software with an insurmountable competitive advantage. Rising demand for digital research in biotech is expanding the market, while AI implementation and new regulatory standards are stimulating the growth of R&D outsourcing, accelerating the time-to-market for new drugs.
פילוחים אנליטיים של חברת Simulations Plus, Inc.

For Simulations Plus, Inc. (SLP), which develops software to optimize FDA clinical trials, this metric determines the net amount of liquid reserves per share minus all liabilities. By analyzing the trend of highly liquid assets per share, an investor assesses the business's actual financial strength, which allows the company to scale development without external borrowing within the high-tech pharmaceutical market.